SFTPD and clear cell adenocarcinoma: Similarly, when the Lu dataset was accessed (32), a similar picture emerged with the expression of SP-D mRNA (SFTPD) in normal ovaries (n = 5), clear cell adenocarcinoma (n = 7), endometrioid adenocarcinoma (n = 9), mucinous adenocarcinoma (n = 9) and serous adenocarcinoma (n = 20; Figure 1B).